SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-115125
Filing Date
2022-11-07
Accepted
2022-11-07 07:22:08
Documents
15
Period of Report
2022-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229838d1_8k.htm   iXBRL 8-K 29772
2 EXHIBIT 1.1 tm2229838d1_ex1-1.htm EX-1.1 253775
3 EXHIBIT 5.1 tm2229838d1_ex5-1.htm EX-5.1 11912
7 GRAPHIC tm2229838d1_ex5-1img001.jpg GRAPHIC 4853
  Complete submission text file 0001104659-22-115125.txt   536803

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20221107.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20221107_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20221107_pre.xml EX-101.PRE 22615
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2229838d1_8k_htm.xml XML 3482
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 221363712
SIC: 2834 Pharmaceutical Preparations